Literature DB >> 7735604

Comprehensive tuberculosis control for patients at high risk for noncompliance.

N Schluger1, C Ciotoli, D Cohen, H Johnson, W N Rom.   

Abstract

The current tuberculosis epidemic in the United States is marked, in many areas, by high rates of noncompliance with antituberculous regimens. In response to this, a comprehensive program of medical, nursing, social services, and supervised therapy was developed at Bellevue Hospital. Most patients were referred to the on-site directly observed therapy program (DOT) located in the hospital. Patients on DOT received daily or twice weekly therapy, and were given incentives to enhance compliance. Outreach was used to track patients who missed appointments. From November 1992 through July 1993, 113 patients were referred. HIV infection, homelessness, illicit drug use, and alcoholism were common. Follow-up revealed that 11 patients were noncompliant and completely lost to follow-up; of the remaining 102, 99% achieved bacteriologic cure. Of the 102 patients who received therapy, 74 attended the Bellevue DOT clinic, 16 attended other DOT programs in the city or received medication at home, and three died of HIV-related, nontuberculous illness. Nine patients were self-medicated and judged treatment successes. We conclude that a comprehensive hospital-based tuberculosis control program is capable of achieving a high degree of success, even in a population at high risk for noncompliance.

Entities:  

Mesh:

Year:  1995        PMID: 7735604     DOI: 10.1164/ajrccm.151.5.7735604

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  15 in total

Review 1.  Tuberculosis: 13. Control of the disease among aboriginal people in Canada.

Authors:  J M FitzGerald; L Wang; R K Elwood
Journal:  CMAJ       Date:  2000-02-08       Impact factor: 8.262

Review 2.  Tuberculosis: 8. The disease in association with HIV infection.

Authors:  J M FitzGerald; S Houston
Journal:  CMAJ       Date:  1999-07-13       Impact factor: 8.262

3.  Homelessness and health.

Authors:  S W Hwang
Journal:  CMAJ       Date:  2001-01-23       Impact factor: 8.262

4.  Dash for DOT.

Authors:  S Shafran; J Conly
Journal:  Can J Infect Dis       Date:  1995-09

5.  Survey of drug-resistant tuberculosis in northwestern Russia from 1984 through 1994.

Authors:  M K Viljanen; B I Vyshnevskiy; T F Otten; E Vyshnevskaya; M Marjamäki; H Soini; P J Laippala; A V Vasilyef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

6.  Outcome of a grocery voucher incentive scheme for low-income tuberculosis patients on directly observed therapy in Singapore.

Authors:  Angeline Poh-Gek Chua; Leo Kang-Yang Lim; Huiyi Ng; Cynthia Bin-Eng Chee; Yee Tang Wang
Journal:  Singapore Med J       Date:  2015-05       Impact factor: 1.858

7.  Outcome of pulmonary tuberculosis treatment in the tertiary care setting--Toronto 1992/93. Tuberculosis Treatment Completion Study Group.

Authors:  W Wobeser; L Yuan; M Naus
Journal:  CMAJ       Date:  1999-03-23       Impact factor: 8.262

8.  Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

Review 9.  Tuberculosis and illicit drug use: review and update.

Authors:  Robert G Deiss; Timothy C Rodwell; Richard S Garfein
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

10.  Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance.

Authors:  I Y Gelmanova; S Keshavjee; V T Golubchikova; V I Berezina; A K Strelis; G V Yanova; S Atwood; M Murray
Journal:  Bull World Health Organ       Date:  2007-09       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.